Expressing support for the recognition of Hidradenitis Suppurativa Awareness Week.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This is a non-binding House resolution that expresses Congressional support for recognizing Hidradenitis Suppurativa (HS) Awareness Week. HS is a chronic, painful skin condition that causes painful lumps and abscesses. The resolution calls for increased public awareness, better medical training, more research funding, improved treatment access, and policies to reduce health disparities for HS patients.
Who Benefits and How
HS patients and their caregivers benefit from increased political recognition and visibility for this often-overlooked condition. Patient advocacy organizations gain Congressional validation of their cause. Medical researchers studying HS gain political support that may help when seeking future research grants. Pharmaceutical and biotechnology companies developing HS treatments receive a political signal of Congressional interest in the disease.
Who Bears the Burden and How
No one bears direct burdens from this resolution. As a non-binding resolution, it creates no new laws, regulations, spending requirements, or mandates. It is purely symbolic political expression.
Key Provisions
• Supports recognizing Hidradenitis Suppurativa Awareness Week
• Calls for increasing public awareness and education about HS among the general public and healthcare professionals
• Encourages promoting timely and accurate diagnosis through improved screening and culturally competent care
• Supports biomedical research to better understand HS causes, treatment effectiveness, and long-term patient outcomes
• Advocates for accelerating development of new treatments and expanding access to existing therapies
• Urges advancing policies that reduce disparities in care access and improve quality of life for HS patients and caregivers
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.
At a Glance
What This Bill Does
Expresses support for Hidradenitis Suppurativa Awareness Week and recognizes the importance of increasing awareness, research, and treatment access for this chronic skin condition.
Who Benefits
- Patients with Hidradenitis Suppurativa
- Medical researchers studying HS
- Healthcare providers treating HS
Who Bears Costs
- None identified - this is a non-binding resolution expressing support
Key Policy Areas
Healthcare, Public Health, Medical Research
Primary Purpose
Expresses support for Hidradenitis Suppurativa Awareness Week and recognizes the importance of increasing awareness, research, and treatment access for this chronic skin condition.
Policy Domains
Legislative Strategy
"Build awareness and political support for addressing a chronic skin condition through recognition of an awareness week and policy objectives"
Identified Gains
- Patients with Hidradenitis Suppurativa
- Medical researchers studying HS
- Healthcare providers treating HS
- Pharmaceutical and biotech companies developing HS treatments
- Patient advocacy organizations for HS
Identified Costs
- None identified - this is a non-binding resolution expressing support
Legislative Progress
In CommitteeMrs. Dingell submitted the following resolution; which was referred to …
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
HS patient advocacy organizations
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
Key Definitions
Terms defined in this bill
Hidradenitis Suppurativa - a chronic skin condition (referenced throughout the resolution)
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology